GSK’s Andrew Witty takes next steps after patent pool
Andrew Witty, CEO of UK’s GlaxoSmithKline said recently on a conference call that his company will publish chemical structures of 13,500 compounds that are seen to be active against the key parasite...
View ArticleGSK’s Witty does some tough talk on India M&A
My colleague Vikas Dandekar, Pharmasianews bureau chief in India, recently tweeted the following comments from GSK CEO Andrew Witty (at an investor call). “I’m not paying 37 times earnings for an...
View Article
More Pages to Explore .....